Genomics England has been successful in delivering the groundbreaking 100,000 Genomes Project and establishing the world’s first national genomic medicine program with Congenica at the heart of both. Congenica has enabled Genomics England to achieve a 50% increase in analytical yield and a 95% reduction in data interpretation times at an unprecedented scale of 2,700 whole genomes per week.
An accurate diagnosis has an immediate impact on a patient’s care. Congenica will in future enable clinicians to decide the most appropriate treatment path much earlier than the traditional diagnostic route.1 Earlier treatment can lead to better patient outcomes, such as improved quality of life or reduced morbidity.2
Receiving an early diagnosis is a big help for patients and their families. Not having answers to their questions can be a source of great anxiety. A swift diagnosis means the patient and their family can access the support they need to make informed choices about their future, sooner.
Congenica can help researchers gain a greater understanding of, and information on, genetic diseases that may have a clinical impact.
Reducing a diagnostic odyssey will allow patients to receive timely and appropriate interventions which benefit patients and providers alike. Solving cases faster will improve the likelihood of achieving better health outcomes, reduce the cost of care for healthcare providers and ease emotional burdens for patients and their families.3
With Congenica, multidisciplinary teams and specialists from around the world can work together, benefiting from the latest information and understanding. The software helps you improve the accuracy of your analysis that may enable more meaningful dialogue in clinical practice.
Analyze and interpret genomic data rapidly, reliably and with complete confidence